Developer docs
API playgroundTry for free, no card

Search company profiles

Berbrick

Full company profile

uuid003z2x8

Namestring
Berbrick
Legal namestring
Berbrick
Websiteurl
berbrick.in
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Berbrick is a private pharmaceutical marketing company headquartered in Mumbai, India, founded in 2018. It markets a portfolio of 61 branded formulations across five therapeutic divisions — Gastro Care, Critical Care, Ortho Care, Respiratory Care, and Nutra Care — covering proton pump inhibitors, prokinetics, probiotics, carbapenem and beta-lactam antibiotics, NSAIDs, muscle relaxants, hepatoprotectives, antihistamines, bronchodilators, and a range of nutritional supplements and enteral nutrition products. The company's go-to-market is sales-led and executed through direct engagement with physicians, hospitals, and clinics, supplemented by a network of pharmaceutical distributors across India and an owned e-commerce storefront at berbrick.in/shop. Brand-building is reinforced by regular participation in Indian specialty medical conferences such as ISN, ESICON, WCN, and ISNSCCON.

Short descriptiontext

Berbrick is a Mumbai-based pharmaceutical marketing company founded in 2018 that sells 61 branded formulations across gastro, critical, orthopedic, respiratory, and nutritional therapeutic divisions to doctors, hospitals, and distributors across India.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMumbai, India
HQ citystring
Mumbai
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical formulations, branded generic medicines, critical care injectables, nutraceutical supplements, enteral nutrition products
Industry4 codes
PRIMARYHLAIAAAI
Gastroenterology & Hepatology Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIACAF
Pulmonology & Allergy Specialty Pharmaceuticals
SECONDARYHLAIAJAB
Specialty Pharmaceutical Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYCRAOAHAG
Pharmacy Front-End & Sundries Distribution (Health & Wellness, Personal Care, Convenience)
NAICS code2 codes
  • Drugs and Druggists' Sundries Merchant Wholesalers42421
  • Pharmaceutical Preparation Manufacturing325412
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Pharmaceutical Formulations
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Product Sales
TypeOne Time License
Description

Marketing and selling pharmaceutical formulations across five therapeutic divisions through direct sales to healthcare professionals, hospitals, clinics, and distribution partners.

berbrick.in
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Personnel, Marketing or Sales, Operations, Technology or R&D
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Berbrick is a pharmaceutical company that markets a portfolio of 61+ branded pharmaceutical formulations across five therapeutic divisions: Gastro Care, Critical Care, Ortho Care, Respiratory Care, and Nutra Care. The offerings include prescription medicines (proton pump inhibitors, antibiotics, NSAIDs, hepatoprotectives), critical care injectables, orthopedic and bone health products, respiratory therapies, and science-backed nutraceutical and enteral nutrition supplements. Products are sold to healthcare professionals, hospitals, distributors, and via a company-owned online shop in India.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Berbrick is a progressive pharmaceutical company headquartered in Mumbai, established in 2018, engaged in the marketing of a wide range of pharmaceutical formulations across five therapeutic divisions: Gastro Care, Critical Care, Ortho Care, Respiratory Care, and Nutra Care. The portfolio includes prescription medicines (antibiotics, proton pump inhibitors, NSAIDs, muscle relaxants, hepatoprotectives), critical care injectables (carbapenems, combination antibiotics, TPN solutions), orthopedic treatments (bone health supplements, NSAIDs, enzyme combinations), respiratory products (antihistamines, bronchodilators, respiratory antibiotics), and nutraceuticals (enteral nutrition formulas, protein supplements, vitamin D supplements, probiotics, and multi-nutrient formulations). The company operates primarily in India with a focus on quality pharmaceuticals and nutritional products.

Product and service34 records
1ESOBRICK 40
CategoryGastro Care
Description

Esomeprazole 40 mg proton pump inhibitor tablet indicated for GERD and functional dyspepsia, marketed to gastroenterologists and general physicians.

2ESOBRICK-D
CategoryGastro Care
Description

PPI-based combination product for acid-related gastrointestinal disorders.

3ESOBRICK-L
CategoryGastro Care
Description

PPI with levosulpiride combination capsule for gastroesophageal reflux and motility disorders.

4ESOBRICK-IT
CategoryGastro Care
Description

Esomeprazole EC 40 mg with Itopride Hydrochloride SR 150 mg capsule for GERD, diabetic gastroparesis, and acid peptic disorders.

5PROBRICK
CategoryGastro Care
Description

Probiotic formulation with elemental zinc, Lactobacillus, and Saccharomyces Boulardii for antibiotic-associated diarrhea, IBS, and functional gut issues.

6PROBRICK PLUS
CategoryGastro Care
Description

Probiotic capsules with Bacillus Clausii for SIBO, IBD, and post-antibiotic recovery.

7ACOTIF
CategoryGastro Care
Description

Acotiamide Hydrochloride 300 mg sustained-release tablet, a first-in-class prokinetic for Postprandial Distress Syndrome in Functional Dyspepsia.

8INBERP-DSR
CategoryGastro Care
Description

Pantoprazole 40 mg with Domperidone 30 mg prolonged release capsule for acid reflux with delayed gastric emptying.

9MEROMIX
CategoryCritical Care
Description

Meropenem 1 g sterile pyrogen-free carbapenem antibiotic injection for intravenous administration against gram-positive, gram-negative, and anaerobic infections.

10PEPTIZA
CategoryCritical Care
Description

Piperacillin and Tazobactam injection for systemic bacterial infections including respiratory, urinary, intra-abdominal, and skin infections.

11GLOMUNE IV
CategoryCritical Care
Description

L-Alanyl-L-Glutamine infusion 20% sterile solution for Total Parenteral Nutrition in critically ill, ICU, severe burn, and post-surgical patients.

12ZOBRICK
CategoryCritical Care
Description

Cefoperazone 1 g with Sulbactam 500 mg injection for treating beta-lactamase producing resistant bacterial infections.

13FLAXMOX CV
CategoryCritical Care
Description

Amoxicillin with Clavulanic Acid and Lactic Acid Bacillus triple formulation antibiotic with probiotic.

14REFABER 550
CategoryCritical Care
Description

Rifaximin 550 mg non-systemic broad-spectrum oral antibiotic tablet for diarrhea associated with IBD/IBS, hepatic encephalopathy, and traveler's diarrhea.

15LINZOBRICK 600MG TAB
CategoryCritical Care
Description

Linezolid 600 mg oxazolidinone-class antibiotic tablet for serious gram-positive bacterial infections including MRSA.

16BERCOX 90MG
CategoryOrtho Care
Description

Etoricoxib 90 mg COX-2 selective NSAID tablet for osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.

17BERCOX MR
CategoryOrtho Care
Description

Etoricoxib 60 mg with Thiocolchicoside 4 mg combination tablet combining anti-inflammatory NSAID with muscle relaxant for musculoskeletal pain.

18THIOBER P
CategoryOrtho Care
Description

Thiocolchicoside, Aceclofenac, and Paracetamol triple combination tablet for pain, fever, and inflammation.

19BERFENAC SP
CategoryOrtho Care
Description

Aceclofenac 100 mg with Paracetamol 325 mg and Serratiopeptidase 15 mg triple action tablet for pain, fever, edema, and musculoskeletal conditions.

20CALBRICK PRO
CategoryOrtho Care
Description

Calcitriol with Calcium Carbonate, DHA, EPA, Boron, Folic Acid, and Methylcobalamin softgel capsule for osteopenia and osteoporosis treatment.

21BERHCQ 200MG
CategoryOrtho Care
Description

Hydroxychloroquine 200 mg tablet for rheumatoid arthritis, polyarthritis associated with Chikungunya, and post-Chikungunya arthritis.

22ALENZA-L
CategoryRespiratory Care
Description

Montelukast 10 mg with Levocetirizine 5 mg film-coated tablet for allergic rhinitis.

23ALENZA-B
CategoryRespiratory Care
Description

Bilastine 20 mg with Montelukast Sodium 10 mg film-coated tablet for allergic conditions.

24NACMAC-AB
CategoryRespiratory Care
Description

Acebrophylline 100 mg with N-Acetylcysteine 600 mg tablet for chronic bronchopulmonary diseases, COPD, bronchial asthma, and pulmonary complications.

25ZAXIS
CategoryRespiratory Care
Description

Azithromycin 500 mg broad-spectrum macrolide antibiotic tablet for respiratory, skin, and genitourinary infections.

26B-NUTRA-1.0 (KESAR ELAICHI)
CategoryNutra Care
Description

Complete and balanced enteral nutrition formula with 25 g high-quality protein, 8 g dietary fiber including FOS, 447 kcal per 100 g, and 39 essential nutrients.

27B-NUTRA-2.0 (MANGO ALMOND)
CategoryNutra Care
Description

100% Whey Protein calorie-dense enteral nutrition formula with 474 kcal per 100 g and 35 g protein, suitable for oral or tube feeding.

28B-NUTRA-DM (KESAR ELAICHI)
CategoryNutra Care
Description

Complete balanced nutrition formulation for individuals with diabetes, featuring low glycemic index, high protein, high fiber, and sucrose-free formulation.

29B-NUTRA-GOLD
CategoryNutra Care
Description

High-protein, high-fiber nutritional formulation with 19.05 g protein per serving, BCAAs, L-Carnitine, and vitamins for muscle support and metabolic recovery.

30B-NUTRA-BCAA
CategoryNutra Care
Description

Oral nutritional supplement with BCAAs (Leucine, Isoleucine, Valine) and Zinc for liver health and chronic liver disease support.

31B-NUTRA-HP
CategoryNutra Care
Description

High protein formulation with 63.5 g protein per 100 g and multimineral combination for immunity boost, in Kesar Elaichi flavour.

32GLOMUNE ZS
CategoryNutra Care
Description

Nutritional sachet with L-Glutamine, Zinc, and Selenium for immune response, tissue repair, and oxidative stress reduction in cancer, critical illness, or burn patients.

33CALBRICK D3 Sachets
CategoryNutra Care
Description

Cholecalciferol (Vitamin D3) 60,000 IU granules in sachets for treatment and prevention of vitamin D deficiency.

34CALBRICK D3 Sachets
CategoryNutra Care
Description

Cholecalciferol (Vitamin D3) 60,000 IU granules in sachets for treatment and prevention of vitamin D deficiency.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Large Indian multi-therapy pharma company with strong presence in anti-infectives, gastro, respiratory and critical care. Highly comparable therapeutic footprint and contract-manufacturing/marketing orientation to Berbrick.

TypeBroad incumbent
Description

Indian specialty pharma with branded generics across multiple therapeutic areas including gastro and respiratory. Comparable to Berbrick in product mix, though materially larger and export-heavy.

TypeEmerging player
Description

Mid-sized Indian pharma with multi-therapy branded-generics focus across gastro, ortho and women's health. Similar in scale, therapy breadth and India-domestic marketing orientation to Berbrick.

TypeBroad incumbent
Description

Large Indian branded-generics pharma company with multi-therapy coverage (gastro, critical care, ortho, respiratory, nutraceuticals). Comparable to Berbrick because of overlapping therapeutic divisions and a similar India-focused marketing-led GTM, though at vastly greater scale.

TypeDirect peer
Description

India-focused specialty pharma company concentrated in chronic therapy areas (gastro, cardio-metabolic, ortho) with a similar super-specialist doctor-focused sales motion. Strongest direct comparability to Berbrick in scale, therapy mix, and channel strategy.

TypeBroad incumbent
Description

India's leading domestic pharma player with broad prescription and OTC/nutraceutical portfolios across gastro, cardiac, respiratory and wellness categories. Comparable to Berbrick in therapy breadth and India-centric distribution model.

TypeBroad incumbent
Description

Mid-to-large Indian pharma with strong gastro/hepatology and chronic-care franchises. Comparable to Berbrick in therapeutic emphasis and India-centric branded-generics GTM.

TypeBroad incumbent
Description

One of India's largest pharma companies with deep respiratory, gastro, and critical care portfolios. A broad incumbent that competes with Berbrick for the same specialist prescriber base across overlapping therapy areas.

TypeEmerging player
Description

India's largest contract manufacturer of pharma formulations with growing own-brand presence across gastro, ortho, and nutraceuticals. Comparable as a fellow India-based multi-therapy formulation company at a similar growth-stage profile.

TypeEmerging player
Description

India-focused branded-generics pharma (part of Emami group) with portfolio overlap in gastro, respiratory, and ortho specialties. Comparable therapeutic mix and India-domestic marketing-led model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Berbrick

Pharmaceutical Formulationsberbrick.in

Berbrick is a Mumbai-based pharmaceutical marketing company founded in 2018 that sells 61 branded formulations across gastro, critical, orthopedic, respiratory, and nutritional therapeutic divisions to doctors, hospitals, and distributors across India.

What Berbrick does

Berbrick is a private pharmaceutical marketing company headquartered in Mumbai, India, founded in 2018. It markets a portfolio of 61 branded formulations across five therapeutic divisions — Gastro Care, Critical Care, Ortho Care, Respiratory Care, and Nutra Care — covering proton pump inhibitors, prokinetics, probiotics, carbapenem and beta-lactam antibiotics, NSAIDs, muscle relaxants, hepatoprotectives, antihistamines, bronchodilators, and a range of nutritional supplements and enteral nutrition products. The company's go-to-market is sales-led and executed through direct engagement with physicians, hospitals, and clinics, supplemented by a network of pharmaceutical distributors across India and an owned e-commerce storefront at berbrick.in/shop. Brand-building is reinforced by regular participation in Indian specialty medical conferences such as ISN, ESICON, WCN, and ISNSCCON.

Berbrick firmographics

Firmographics
Name
Berbrick
Legal name
Berbrick
Website
https://berbrick.in
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
11–50 employees
Short description
Berbrick is a Mumbai-based pharmaceutical marketing company founded in 2018 that sells 61 branded formulations across gastro, critical, orthopedic, respiratory, and nutritional therapeutic divisions to doctors, hospitals, and distributors across India.
Ownership category
akta.pro rank

Berbrick industry classification

Industry
Product category
Pharmaceutical Formulations
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (42421), Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLAIAAAI
Gastroenterology & Hepatology Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIACAF
Pulmonology & Allergy Specialty Pharmaceuticals
SECONDARYHLAIAJAB
Specialty Pharmaceutical Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYCRAOAHAG
Pharmacy Front-End & Sundries Distribution (Health & Wellness, Personal Care, Convenience)

Keywords

  • Pharmaceutical formulations
  • Branded generic medicines
  • Critical care injectables
  • Nutraceutical supplements
  • Enteral nutrition products

Where Berbrick is headquartered

Location

Headquarters

HQ city
Mumbai
HQ country
India
HQ region
Asia

Offices1 record

Markets served

Berbrick business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Marketing or Sales, Operations, Technology or R&D

Revenue model

  1. Pharmaceutical Product Sales: Marketing and selling pharmaceutical formulations across five therapeutic divisions through direct sales to healthcare professionals, hospitals, clinics, and distribution partners.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Berbrick product offering

Product offering

Core offering

Berbrick is a pharmaceutical company that markets a portfolio of 61+ branded pharmaceutical formulations across five therapeutic divisions: Gastro Care, Critical Care, Ortho Care, Respiratory Care, and Nutra Care. The offerings include prescription medicines (proton pump inhibitors, antibiotics, NSAIDs, hepatoprotectives), critical care injectables, orthopedic and bone health products, respiratory therapies, and science-backed nutraceutical and enteral nutrition supplements. Products are sold to healthcare professionals, hospitals, distributors, and via a company-owned online shop in India.

Product overview

Berbrick is a progressive pharmaceutical company headquartered in Mumbai, established in 2018, engaged in the marketing of a wide range of pharmaceutical formulations across five therapeutic divisions: Gastro Care, Critical Care, Ortho Care, Respiratory Care, and Nutra Care. The portfolio includes prescription medicines (antibiotics, proton pump inhibitors, NSAIDs, muscle relaxants, hepatoprotectives), critical care injectables (carbapenems, combination antibiotics, TPN solutions), orthopedic treatments (bone health supplements, NSAIDs, enzyme combinations), respiratory products (antihistamines, bronchodilators, respiratory antibiotics), and nutraceuticals (enteral nutrition formulas, protein supplements, vitamin D supplements, probiotics, and multi-nutrient formulations). The company operates primarily in India with a focus on quality pharmaceuticals and nutritional products.

Differentiator

Problem solved

Functional benefit

Products and services

  • ESOBRICK 40 Esomeprazole 40 mg proton pump inhibitor tablet indicated for GERD and functional dyspepsia, marketed to gastroenterologists and general physicians.
  • ESOBRICK-D PPI-based combination product for acid-related gastrointestinal disorders.
  • ESOBRICK-L PPI with levosulpiride combination capsule for gastroesophageal reflux and motility disorders.
  • ESOBRICK-IT Esomeprazole EC 40 mg with Itopride Hydrochloride SR 150 mg capsule for GERD, diabetic gastroparesis, and acid peptic disorders.
  • PROBRICK Probiotic formulation with elemental zinc, Lactobacillus, and Saccharomyces Boulardii for antibiotic-associated diarrhea, IBS, and functional gut issues.
  • PROBRICK PLUS Probiotic capsules with Bacillus Clausii for SIBO, IBD, and post-antibiotic recovery.
  • ACOTIF Acotiamide Hydrochloride 300 mg sustained-release tablet, a first-in-class prokinetic for Postprandial Distress Syndrome in Functional Dyspepsia.
  • INBERP-DSR Pantoprazole 40 mg with Domperidone 30 mg prolonged release capsule for acid reflux with delayed gastric emptying.
  • MEROMIX Meropenem 1 g sterile pyrogen-free carbapenem antibiotic injection for intravenous administration against gram-positive, gram-negative, and anaerobic infections.
  • PEPTIZA Piperacillin and Tazobactam injection for systemic bacterial infections including respiratory, urinary, intra-abdominal, and skin infections.
  • GLOMUNE IV L-Alanyl-L-Glutamine infusion 20% sterile solution for Total Parenteral Nutrition in critically ill, ICU, severe burn, and post-surgical patients.
  • ZOBRICK Cefoperazone 1 g with Sulbactam 500 mg injection for treating beta-lactamase producing resistant bacterial infections.
  • FLAXMOX CV Amoxicillin with Clavulanic Acid and Lactic Acid Bacillus triple formulation antibiotic with probiotic.
  • REFABER 550 Rifaximin 550 mg non-systemic broad-spectrum oral antibiotic tablet for diarrhea associated with IBD/IBS, hepatic encephalopathy, and traveler's diarrhea.
  • LINZOBRICK 600MG TAB Linezolid 600 mg oxazolidinone-class antibiotic tablet for serious gram-positive bacterial infections including MRSA.
  • BERCOX 90MG Etoricoxib 90 mg COX-2 selective NSAID tablet for osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.
  • BERCOX MR Etoricoxib 60 mg with Thiocolchicoside 4 mg combination tablet combining anti-inflammatory NSAID with muscle relaxant for musculoskeletal pain.
  • THIOBER P Thiocolchicoside, Aceclofenac, and Paracetamol triple combination tablet for pain, fever, and inflammation.
  • BERFENAC SP Aceclofenac 100 mg with Paracetamol 325 mg and Serratiopeptidase 15 mg triple action tablet for pain, fever, edema, and musculoskeletal conditions.
  • CALBRICK PRO Calcitriol with Calcium Carbonate, DHA, EPA, Boron, Folic Acid, and Methylcobalamin softgel capsule for osteopenia and osteoporosis treatment.
  • BERHCQ 200MG Hydroxychloroquine 200 mg tablet for rheumatoid arthritis, polyarthritis associated with Chikungunya, and post-Chikungunya arthritis.
  • ALENZA-L Montelukast 10 mg with Levocetirizine 5 mg film-coated tablet for allergic rhinitis.
  • ALENZA-B Bilastine 20 mg with Montelukast Sodium 10 mg film-coated tablet for allergic conditions.
  • NACMAC-AB Acebrophylline 100 mg with N-Acetylcysteine 600 mg tablet for chronic bronchopulmonary diseases, COPD, bronchial asthma, and pulmonary complications.
  • ZAXIS Azithromycin 500 mg broad-spectrum macrolide antibiotic tablet for respiratory, skin, and genitourinary infections.
  • B-NUTRA-1.0 (KESAR ELAICHI) Complete and balanced enteral nutrition formula with 25 g high-quality protein, 8 g dietary fiber including FOS, 447 kcal per 100 g, and 39 essential nutrients.
  • B-NUTRA-2.0 (MANGO ALMOND) 100% Whey Protein calorie-dense enteral nutrition formula with 474 kcal per 100 g and 35 g protein, suitable for oral or tube feeding.
  • B-NUTRA-DM (KESAR ELAICHI) Complete balanced nutrition formulation for individuals with diabetes, featuring low glycemic index, high protein, high fiber, and sucrose-free formulation.
  • B-NUTRA-GOLD High-protein, high-fiber nutritional formulation with 19.05 g protein per serving, BCAAs, L-Carnitine, and vitamins for muscle support and metabolic recovery.
  • B-NUTRA-BCAA Oral nutritional supplement with BCAAs (Leucine, Isoleucine, Valine) and Zinc for liver health and chronic liver disease support.
  • B-NUTRA-HP High protein formulation with 63.5 g protein per 100 g and multimineral combination for immunity boost, in Kesar Elaichi flavour.
  • GLOMUNE ZS Nutritional sachet with L-Glutamine, Zinc, and Selenium for immune response, tissue repair, and oxidative stress reduction in cancer, critical illness, or burn patients.
  • CALBRICK D3 Sachets Cholecalciferol (Vitamin D3) 60,000 IU granules in sachets for treatment and prevention of vitamin D deficiency.
  • CALBRICK D3 Sachets Cholecalciferol (Vitamin D3) 60,000 IU granules in sachets for treatment and prevention of vitamin D deficiency.

Companies that use Berbrick

Customer profile

Segments5 records

Ideal customer profiles2 records

Berbrick technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Berbrick partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves4 records

Expansion highlights4 records

Berbrick competitors and assessment

Company assessment

Broad incumbents

  • Macleods Pharmaceuticals: Large Indian multi-therapy pharma company with strong presence in anti-infectives, gastro, respiratory and critical care. Highly comparable therapeutic footprint and contract-manufacturing/marketing orientation to Berbrick.
  • Ajanta Pharma: Indian specialty pharma with branded generics across multiple therapeutic areas including gastro and respiratory. Comparable to Berbrick in product mix, though materially larger and export-heavy.
  • Alkem Laboratories: Large Indian branded-generics pharma company with multi-therapy coverage (gastro, critical care, ortho, respiratory, nutraceuticals). Comparable to Berbrick because of overlapping therapeutic divisions and a similar India-focused marketing-led GTM, though at vastly greater scale.
  • Mankind Pharma: India's leading domestic pharma player with broad prescription and OTC/nutraceutical portfolios across gastro, cardiac, respiratory and wellness categories. Comparable to Berbrick in therapy breadth and India-centric distribution model.
  • Torrent Pharmaceuticals: Mid-to-large Indian pharma with strong gastro/hepatology and chronic-care franchises. Comparable to Berbrick in therapeutic emphasis and India-centric branded-generics GTM.
  • Cipla: One of India's largest pharma companies with deep respiratory, gastro, and critical care portfolios. A broad incumbent that competes with Berbrick for the same specialist prescriber base across overlapping therapy areas.

Emerging players

  • Corona Remedies: Mid-sized Indian pharma with multi-therapy branded-generics focus across gastro, ortho and women's health. Similar in scale, therapy breadth and India-domestic marketing orientation to Berbrick.
  • Akums Drugs & Pharmaceuticals: India's largest contract manufacturer of pharma formulations with growing own-brand presence across gastro, ortho, and nutraceuticals. Comparable as a fellow India-based multi-therapy formulation company at a similar growth-stage profile.
  • Zuventus Healthcare: India-focused branded-generics pharma (part of Emami group) with portfolio overlap in gastro, respiratory, and ortho specialties. Comparable therapeutic mix and India-domestic marketing-led model.

Direct peers

  • Eris Lifesciences: India-focused specialty pharma company concentrated in chronic therapy areas (gastro, cardio-metabolic, ortho) with a similar super-specialist doctor-focused sales motion. Strongest direct comparability to Berbrick in scale, therapy mix, and channel strategy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Berbrick social profiles

Digital presence

Berbrick financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Berbrick leadership team

Management profile

Number of profiles

Berbrick funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Berbrick M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Berbrick

What does Berbrick do?

Berbrick is a pharmaceutical company that markets a portfolio of 61+ branded pharmaceutical formulations across five therapeutic divisions: Gastro Care, Critical Care, Ortho Care, Respiratory Care, and Nutra Care. The offerings include prescription medicines (proton pump inhibitors, antibiotics, NSAIDs, hepatoprotectives), critical care injectables, orthopedic and bone health products, respiratory therapies, and science-backed nutraceutical and enteral nutrition supplements. Products are sold to healthcare professionals, hospitals, distributors, and via a company-owned online shop in India.

Is Berbrick a public or private company?

Berbrick is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Berbrick founded?

Berbrick was founded in 2018. It employs 11 to 50 people.

Where is Berbrick based?

Berbrick is headquartered in Mumbai, India, in the Asia region.

How does Berbrick make money?

One revenue line is on record: pharmaceutical Product Sales.

Who are Berbrick's main competitors?

Broad incumbents on record are Macleods Pharmaceuticals, Ajanta Pharma, Alkem Laboratories, Mankind Pharma, Torrent Pharmaceuticals and Cipla. Emerging players are Corona Remedies, Akums Drugs & Pharmaceuticals and Zuventus Healthcare. Eris Lifesciences is listed as a direct peer.

Does Berbrick have an API?

No public API is recorded for Berbrick.

What industry is Berbrick in?

Berbrick's product category is Pharmaceutical Formulations. Its primary akta.pro industry code is HLAIAAAI, Gastroenterology & Hepatology Pharmaceuticals, with a secondary code of HLAIACAF, Pulmonology & Allergy Specialty Pharmaceuticals. Its NAICS code is 42421 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales